ASLAN PHARMACEUTICALS LTD's ticker is ASLN and the CUSIP is 04522R101. A total of 16 filers reported holding ASLAN PHARMACEUTICALS LTD in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $724,000 | -45.0% | 418,671 | -2.4% | 0.00% | 0.0% |
Q2 2019 | $1,317,000 | -28.3% | 428,975 | -3.0% | 0.00% | -50.0% |
Q1 2019 | $1,836,000 | +3.3% | 442,194 | -1.8% | 0.00% | 0.0% |
Q4 2018 | $1,778,000 | -48.6% | 450,133 | 0.0% | 0.00% | -50.0% |
Q3 2018 | $3,457,000 | -12.7% | 450,133 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $3,961,000 | – | 450,133 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vivo Capital, LLC | 568,182 | $1,068,181 | 0.12% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |